Published in PLoS One on May 26, 2015
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil. PLoS One (2017) 0.75
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review. PLoS One (2017) 0.75
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med (2009) 65.36
Leishmaniasis worldwide and global estimates of its incidence. PLoS One (2012) 18.07
Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis (2004) 11.90
Advances in leishmaniasis. Lancet (2005) 8.95
Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ (2001) 7.13
Empirical assessment of effect of publication bias on meta-analyses. BMJ (2000) 5.96
Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites. PLoS Med (2006) 2.60
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis. Int J Dermatol (2008) 2.06
Leishmaniasis: drugs in the clinic, resistance and new developments. Drug Resist Updat (2004) 1.96
Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis (2005) 1.91
Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg (1992) 1.83
Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World. Acta Trop (2011) 1.70
Cutaneous leishmaniasis. Clin Dermatol (2007) 1.61
Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Clin Infect Dis (1998) 1.55
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitol Res (2007) 1.52
A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran. Int J Dermatol (1999) 1.48
Cutaneous leishmaniasis treated with controlled localized heating. Arch Dermatol (1992) 1.48
Interventions for American cutaneous and mucocutaneous leishmaniasis. Cochrane Database Syst Rev (2009) 1.45
Leishmaniasis: current treatment and prospects for new drugs and vaccines. Curr Med Chem (2009) 1.43
Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop (2004) 1.34
Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chloride: a clinical study under field conditions in Ecuador. Trans R Soc Trop Med Hyg (1994) 1.12
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala. Am J Trop Med Hyg (1990) 1.10
Treatment of New World cutaneous and mucosal leishmaniases. Clin Dermatol (1997) 1.08
Current treatment for cutaneous leishmaniasis: a review. Am J Ther (2009) 1.08
Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis. QJM (1999) 1.04
Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis. Am J Trop Med Hyg (2010) 1.04
Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis. Clin Infect Dis (2007) 1.00
Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol (2006) 0.99
Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blind, controlled clinical trial. J Drugs Dermatol (2005) 0.95
A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. PLoS Negl Trop Dis (2010) 0.95
[Gender and cutaneous leishmaniasis in Colombia]. Cad Saude Publica (2001) 0.95
Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1995) 0.95
Treatment of cutaneous leishmaniasis (Old World). Clin Dermatol (1997) 0.90
[knowledge level about of American tegumentary leishmaniasis (ATL) and use of alternative therapies in an endemic area in the Amazon Region in the State of Maranhão, Brazil]. Cad Saude Publica (2002) 0.90
The traditional and conventional medical treatment of cutaneous leishmaniasis in rural Ecuador. Rev Panam Salud Publica (2001) 0.90
[Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis]. Rev Soc Bras Med Trop (1996) 0.89
Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate. Clin Exp Dermatol (2007) 0.89
Heat, Oriental sore, and HIV. Lancet (2011) 0.88
Treatment of cutaneous leishmaniasis with localized current field (radio frequency) in Tabasco, Mexico. Am J Trop Med Hyg (1997) 0.88
Heat therapy for cutaneous leishmaniasis elicits a systemic cytokine response similar to that of antimonial (Glucantime) therapy. Trans R Soc Trop Med Hyg (2005) 0.88
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. Trials (2012) 0.87
Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial. Mil Med (2012) 0.86
[The evaluation of the tolerance and nephrotoxicity of pentavalent antimony administered in a dose of 40 mg Sb V/kg/day, 12/12 hr, for 30 days in the mucocutaneous form of leishmaniasis]. Rev Soc Bras Med Trop (1998) 0.86
Long-term efficacy of single-dose radiofrequency-induced heat therapy vs. intralesional antimonials for cutaneous leishmaniasis in India. Br J Dermatol (2013) 0.86
[Cutaneous leishmaniasis in France: towards the end of injectable therapy?]. Bull Soc Pathol Exot (2003) 0.81
A randomized, double-blind, clinical trial of topical clotrimazole versus miconazole for treatment of cutaneous leishmaniasis in the eastern province of Saudi Arabia. Am J Trop Med Hyg (1995) 0.81
[Current situation and future of antileishmanial therapy in Colombia]. Biomedica (2006) 0.80
Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia. Rev Inst Med Trop Sao Paulo (2013) 0.77